Back to search

Peptide record

TPDB07232

Antibacterial Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07232
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia
standard
No
A 13-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
RRPWRWPWWPWRR
Physicochemical Analysis
C100H133N33O14
ANDCEQGHILKMFSTYV
RW
2021.37
13.00
5
0
5
+5
-3.85
-2.446
0.00
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
27500
1360.46
0
Residue Composition
number
0
A
5
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
3
P
0
S
0
T
5
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 5 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 3 S: 0 T: 0 W: 5 Y: 0 V: 0
Chemical Descriptors
13
C100H133N33O14
2021.37
13.00
+5
-3.85
-2.446
Evidence Records 3 records
Evidence 1 Activity

Activity

15.39% hemolysis
Toxicity
250 µg/mL
Hemolytic Cytotoxic
15.39% hemolysis | 250 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae | PLoS One | 2015
Evidence 2 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human lung normal epithelial cells NL20

Target

Human lung normal epithelial cells NL20

Source & Reference

NA
DBAASP
Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae | PLoS One | 2015
Evidence 3 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.26046345] IN2 showed 15.39% hemolytic activity at concentration of 250µg/ml against human RBCs. | Cytotoxicity: [Ref.26046345] The cell viability of NL-20 cell line is not affected (<10%) below 62.5 µg/ml. The cell viability of NL-20 is 40% and 19% at peptide concentrations of 125 and 250 µg/ml.## The cell viability of WRL-68 cell line is not affected (<10%) bel

Target

erythrocytes

Source & Reference

NA
DRAMP
PLoS One. 2015 Jun 5 10(6):e0128532.